Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: Current status and global perspectives

Giovanni Battista Migliori, Rosella Centis, Chris Lange, Morgan D Arcy Richardson, Giovanni Sotgiu

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose of Review: Drug resistance, particularly through multidrug-resistant tuberculosis (TB) and extensively drug-resistant TB strains, poses a real threat to TB control worldwide. Recent reports from the WHO and the International Union Against Tuberculosis and Lung Disease demonstrate that the emerging epidemic of drug-resistant TB is a global problem, although emphasis has been placed on several 'hot spots' because of lack of good global data. Recent Findings: The present article is aimed at reviewing the available information on drug-resistant TB with special focus on the features of the epidemic in Europe, Russia, Latin America, Asia and specifically China, and to discuss the global perspectives related to drug-resistant TB control and care. Summary: Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs and other reasons related to prescribers, patients and drug producers. Although there is an urgent need for new drugs, a sound public health approach is necessary for their introduction in clinical treatment settings to prevent/avoid creating additional resistance, as has already been observed for first and second-line anti-TB drugs in many settings.

Original languageEnglish
Pages (from-to)171-179
Number of pages9
JournalCurrent Opinion in Pulmonary Medicine
Volume16
Issue number3
DOIs
Publication statusPublished - May 2010

Fingerprint

Multidrug-Resistant Tuberculosis
South America
Russia
China
Tuberculosis
Pharmaceutical Preparations
Extensively Drug-Resistant Tuberculosis
Latin America
Drug Resistance
Public Health

Keywords

  • Asia
  • China
  • Drug-resistant tuberculosis
  • Europe
  • Extensively drug-resistant tuberculosis
  • Latin America
  • Multidrug-resistant tuberculosis
  • Russia
  • Tuberculosis

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia : Current status and global perspectives. / Migliori, Giovanni Battista; Centis, Rosella; Lange, Chris; Richardson, Morgan D Arcy; Sotgiu, Giovanni.

In: Current Opinion in Pulmonary Medicine, Vol. 16, No. 3, 05.2010, p. 171-179.

Research output: Contribution to journalArticle

@article{d8fa0a0e763a4280b1f627f9dcda3c54,
title = "Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: Current status and global perspectives",
abstract = "Purpose of Review: Drug resistance, particularly through multidrug-resistant tuberculosis (TB) and extensively drug-resistant TB strains, poses a real threat to TB control worldwide. Recent reports from the WHO and the International Union Against Tuberculosis and Lung Disease demonstrate that the emerging epidemic of drug-resistant TB is a global problem, although emphasis has been placed on several 'hot spots' because of lack of good global data. Recent Findings: The present article is aimed at reviewing the available information on drug-resistant TB with special focus on the features of the epidemic in Europe, Russia, Latin America, Asia and specifically China, and to discuss the global perspectives related to drug-resistant TB control and care. Summary: Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs and other reasons related to prescribers, patients and drug producers. Although there is an urgent need for new drugs, a sound public health approach is necessary for their introduction in clinical treatment settings to prevent/avoid creating additional resistance, as has already been observed for first and second-line anti-TB drugs in many settings.",
keywords = "Asia, China, Drug-resistant tuberculosis, Europe, Extensively drug-resistant tuberculosis, Latin America, Multidrug-resistant tuberculosis, Russia, Tuberculosis",
author = "Migliori, {Giovanni Battista} and Rosella Centis and Chris Lange and Richardson, {Morgan D Arcy} and Giovanni Sotgiu",
year = "2010",
month = "5",
doi = "10.1097/MCP.0b013e328337573e",
language = "English",
volume = "16",
pages = "171--179",
journal = "Current Opinion in Pulmonary Medicine",
issn = "1070-5287",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia

T2 - Current status and global perspectives

AU - Migliori, Giovanni Battista

AU - Centis, Rosella

AU - Lange, Chris

AU - Richardson, Morgan D Arcy

AU - Sotgiu, Giovanni

PY - 2010/5

Y1 - 2010/5

N2 - Purpose of Review: Drug resistance, particularly through multidrug-resistant tuberculosis (TB) and extensively drug-resistant TB strains, poses a real threat to TB control worldwide. Recent reports from the WHO and the International Union Against Tuberculosis and Lung Disease demonstrate that the emerging epidemic of drug-resistant TB is a global problem, although emphasis has been placed on several 'hot spots' because of lack of good global data. Recent Findings: The present article is aimed at reviewing the available information on drug-resistant TB with special focus on the features of the epidemic in Europe, Russia, Latin America, Asia and specifically China, and to discuss the global perspectives related to drug-resistant TB control and care. Summary: Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs and other reasons related to prescribers, patients and drug producers. Although there is an urgent need for new drugs, a sound public health approach is necessary for their introduction in clinical treatment settings to prevent/avoid creating additional resistance, as has already been observed for first and second-line anti-TB drugs in many settings.

AB - Purpose of Review: Drug resistance, particularly through multidrug-resistant tuberculosis (TB) and extensively drug-resistant TB strains, poses a real threat to TB control worldwide. Recent reports from the WHO and the International Union Against Tuberculosis and Lung Disease demonstrate that the emerging epidemic of drug-resistant TB is a global problem, although emphasis has been placed on several 'hot spots' because of lack of good global data. Recent Findings: The present article is aimed at reviewing the available information on drug-resistant TB with special focus on the features of the epidemic in Europe, Russia, Latin America, Asia and specifically China, and to discuss the global perspectives related to drug-resistant TB control and care. Summary: Drug-resistant TB originates from different human errors, including misuse of anti-TB drugs and other reasons related to prescribers, patients and drug producers. Although there is an urgent need for new drugs, a sound public health approach is necessary for their introduction in clinical treatment settings to prevent/avoid creating additional resistance, as has already been observed for first and second-line anti-TB drugs in many settings.

KW - Asia

KW - China

KW - Drug-resistant tuberculosis

KW - Europe

KW - Extensively drug-resistant tuberculosis

KW - Latin America

KW - Multidrug-resistant tuberculosis

KW - Russia

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=77951048363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951048363&partnerID=8YFLogxK

U2 - 10.1097/MCP.0b013e328337573e

DO - 10.1097/MCP.0b013e328337573e

M3 - Article

C2 - 20134324

AN - SCOPUS:77951048363

VL - 16

SP - 171

EP - 179

JO - Current Opinion in Pulmonary Medicine

JF - Current Opinion in Pulmonary Medicine

SN - 1070-5287

IS - 3

ER -